German biotech Akribion Therapeutics has emerged from stealth with 8 million euros ($9 million) in seed funding to accelerate ...
Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...
Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...
MR PORTER’s Pre-Spring 2025 campaign offers a fresh perspective on classic styles and new trends, designed to update and ...
US President Donald Trump has declared his intention to cut funding to South Africa due to the country’s new land expropriation policy. The announcement came on Sunday, following criticisms of the ...